Update shared on 30 Oct 2025
Fair value Decreased 1.06%Analysts have slightly lowered their price target for Wesfarmers, reducing it from $82.51 to $81.64. They cite modest adjustments to discount rates, revenue growth expectations, and profit margin forecasts as the reasons for this change.
Analyst Commentary
Analysts provided further insight into Wesfarmers' revised price target, evaluating both positive and negative factors impacting the company’s outlook and valuation.
Bullish Takeaways
- Bullish analysts highlight that Wesfarmers maintains a strong balance sheet, which supports future investments and potential expansion opportunities.
- Steady consumer demand in core business segments is viewed as a key driver for near-term revenue resilience, even during broader market volatility.
- Ongoing operational improvements and disciplined cost management are expected to help preserve profit margins, according to optimistic forecasts.
- Longer-term growth initiatives, particularly in the digital and healthcare arenas, are seen as potentially enhancing the company's earnings trajectory.
Bearish Takeaways
- Bearish analysts express concern over modest reductions in profit growth expectations, citing increased competition and margin pressures.
- Uncertainty in the broader economic environment could weigh on discretionary spending, which may affect key business units.
- Adjustments to discount rates indicate a more cautious approach to future cash flow projections, leading to tempered valuation multiples.
- Potential regulatory changes or supply chain disruptions remain ongoing risks for the company’s execution.
What's in the News
- Wesfarmers announced a proposed capital management initiative, including a distribution of $1.50 per share. This consists of a $1.10 capital component and a $0.40 fully-franked special dividend, subject to final approval and an ATO ruling. If approved, payments are expected on December 4, 2025 (AGM announcement).
- The company declared a fully franked dividend of AUD 1.11 per share for the six months ended June 30, 2025. The ex date is September 2, 2025, with payment scheduled for October 7, 2025 (Company announcement).
Valuation Changes
- The consensus analyst price target has decreased slightly, moving from A$82.51 to A$81.64.
- The discount rate has fallen modestly, from 8.07% to 8.00%.
- Revenue growth expectations have been trimmed, lowering from 4.27% to 4.15%.
- Net profit margin forecasts have reduced from 6.66% to 6.53%.
- The future P/E ratio is projected to rise from 34.24x to 34.60x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.